A phase Ib/II study of atezolizumab plus tivozanib in pancreatic, gallbladder, and bile duct malignancies.
| Autor: | Ramnaraign, Brian Hemendra, Lee, Ji-Hyun, Sahin, Ilyas, Rogers, Sherise C., Thomas, Ryan M., Allegra, Carmen J., DeRemer, David L., George, Thomas J., Chatzkel, Jonathan Alexander |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pTPS715-TPS715, 117p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|